Time to incorporate time in cost-effectiveness analysis

被引:15
|
作者
van de Wetering, Gijs [1 ]
Woertman, Willem H. [1 ]
Adang, Eddy M. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Epidemiol Biostat & HTA, Med Ctr, NL-6500 HB Nijmegen, Netherlands
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2012年 / 13卷 / 03期
关键词
Time; Economic evaluation; Short run; Cost-effectiveness; DECISION-MAKING; ECONOMIC-EVALUATION; CARE;
D O I
10.1007/s10198-011-0374-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
Cost-effectiveness analysis as a means to evaluate medical innovations has become well accepted in the UK and several other Western countries. An important assumption underlying this method is that costs and effects are constant over time. In reality, however, and especially in the short run, variations in costs and effects are likely to occur. These variations can lead to considerable deviations from the outcome of a conventional economic evaluation, which in turn may lead to serious implementation problems at a local level. Taking time into account explicitly in economic evaluations in health care may enhance their utility for both societal and local decision making, and may ultimately smooth the adoption of new and basically cost-effective health care technologies.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [21] TIME PREFERENCE IN MEDICAL DECISION-MAKING AND COST-EFFECTIVENESS ANALYSIS
    REDELMEIER, DA
    HELLER, DN
    [J]. MEDICAL DECISION MAKING, 1993, 13 (03) : 212 - 217
  • [22] Apical support procedures at the time of benign hysterectomy: A cost-effectiveness analysis
    Wang, R.
    Tulikangas, P.
    Harvie, H.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (06) : S773 - S773
  • [23] Has the time come for cost-effectiveness analysis in US health care?
    Bryan, Stirling
    Sofaer, Shoshanna
    Siegelberg, Taryn
    Gold, Marthe
    [J]. HEALTH ECONOMICS POLICY AND LAW, 2009, 4 (04) : 425 - 443
  • [24] Pharmacogenomics and the Evolution of HealthcareIs it Time for Cost-Effectiveness Analysis at the Individual Level?
    Mohan V. Bala
    Gary A. Zarkin
    [J]. PharmacoEconomics, 2004, 22 : 495 - 498
  • [25] Antibiotic prophylaxis at the time of dental implant placement: a cost-effectiveness analysis
    Zhurakivska, Khrystyna
    Lo Russo, Lucio
    Lo Muzio, Lorenzo
    Caponio, Vito Carlo Alberto
    Laino, Luigi
    Arena, Claudia
    Cirillo, Nicola
    Troiano, Giuseppe
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [26] Pharmacogenomics and the evolution of healthcare - Is it time for cost-effectiveness analysis at the individual level?
    Bala, MV
    Zarkin, GA
    [J]. PHARMACOECONOMICS, 2004, 22 (08) : 495 - 498
  • [27] Cost-effectiveness Analysis of Universal Cystoscopy at the Time of Benign Laparoscopic Hysterectomy
    Luchristt, Douglas
    Geynisman-Tan, Julia
    Mueller, Margaret G.
    Kenton, Kimberly
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2021, 28 (08) : 1470 - 1483
  • [28] Time to resume routine smallpox vaccination in the US? A cost-effectiveness analysis
    Davis, MM
    Kemper, AR
    Wheeler, JRC
    Clark, SJ
    Freed, GL
    [J]. PEDIATRIC RESEARCH, 2002, 51 (04) : 133A - 133A
  • [29] The influence of time horizon on results of cost-effectiveness analyses
    Kim, David D.
    Wilkinson, Colby L.
    Pope, Elle F.
    Chambers, James D.
    Cohen, Joshua T.
    Neumann, Peter J.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (06) : 615 - 623
  • [30] Time to Publication of Cost-effectiveness Analyses for Medical Devices
    Everhart, Alexander O.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (05): : 265 - 268